ZTS Jan 2026 260.000 call
| Previous close | 6.75 |
| Open | 6.75 |
| Bid | 2.90 |
| Ask | 5.70 |
| Strike | 260.00 |
| Expiry date | 2026-01-16 |
| Day's range | 6.75 - 6.75 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
- Reuters
Zoetis beats profit estimates on strong demand for pet products
Animal healthcare company Zoetis surpassed analysts' expectations for first-quarter profit on Thursday, helped by strong demand for its medicines and vaccines for pets. Zoetis deals with vaccines, medicines and diagnostic solutions for animals and manufactures products for livestock and fish, which it markets in more than 40 countries. The company posted adjusted profit of $1.38 per share for the first quarter, beating analysts' average estimate of $1.34 per share, according to LSEG data.
Investor's Business DailyZoetis Earnings Top; Pet Drugmaker Rises
Zoetis earnings and sales slightly beat first-quarter estimates for the pet drugmaker. Shares rose modestly.
Business WireZoetis Announces First Quarter 2024 Results
PARSIPPANY, N.J., May 02, 2024--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the first quarter of 2024 and updated its guidance for full year 2024.
